Skip to content

DiRx Appoints Peter Licata as Chief Financial Officer

Monroe, New Jersey, October 13, 2020

DiRx Inc., an emerging digital health company, announced today that Peter Licata has joined the company as its Chief Financial Officer (CFO).

Peter is an experienced financial leader with a varied and extensive base of experience that covers all aspects of the finance and accounting functions of an organization. Peter has over 25 years of financial and accounting experience, 20 of which have been in the pharmaceutical industry. This experience includes both large and small corporate entities such as Merck-Medco, Taro Pharmaceuticals, Ascend Labs, Rising Pharmaceuticals and Edenbridge Pharmaceuticals.

Peter has a B.S. in Accounting from State University of New York at New Paltz and is a Certified Public Accountant, licensed in the State of New York.

"I'm so pleased to be working with Peter again," said Satish Srinivasan, CEO of DiRx. "Our previous association in growing a generic pharma business profitably yielded great results and I'm looking forward to Peter's partnership and solid support in DiRx's growth as well."

"I could not be happier than joining the DiRx team," said Peter. "DiRx is going to refocus the pharmaceutical industry by getting back to basics. We will center our attention on providing safe, effective and affordable medications, paying particular attention to uninsured and underinsured populations."

About the Company

Headquartered in Monroe, New Jersey, DiRx is a new type of digital pharmacy that is designed to deliver significant savings to consumers on most commonly prescribed, FDA-approved, generic medications delivered to their doorstep on a recurring subscription model. Envisioned by a team of experienced health care leaders whose goal is to put consumers first and enhance affordability, DiRx's service will be available on a cash-only subscription basis, without insurance.

For more information:

Phone: 908.356.0764